Outlook Therapeutics, Inc. (OTLK)
0.6405
-0.03
(-3.90%)
USD |
NASDAQ |
Sep 08, 16:00
0.6447
0.00 (0.00%)
Pre-Market: 08:35
Outlook Therapeutics Profit Margin (Quarterly) : -233.6K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -233.6K% |
| March 31, 2026 | -3.50K% |
| December 31, 2025 | |
| June 30, 2025 | -1.34K% |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -172.5% |
| June 30, 2019 | -760.7% |
| March 31, 2019 | -1.61K% |
| December 31, 2018 | -912.5% |
| September 30, 2018 | -1.62K% |
| June 30, 2018 | -1.09K% |
| March 31, 2018 | -1.03K% |
| December 31, 2017 | -2.24K% |
| September 30, 2017 | -260.3% |
| June 30, 2017 | -1.76K% |
| March 31, 2017 | -2.65K% |
| December 31, 2016 | -6.30K% |
| September 30, 2016 | -2.14K% |
| June 30, 2016 | -4.51K% |
| March 31, 2016 | -356.1% |
| December 31, 2015 | -1.70K% |
| December 31, 2014 | -167.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Valion Bio, Inc. | -- |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -315.4% |
| Return on Invested Capital | -11.57K% |
| Gross Profit Margin (Quarterly) | -254.0% |
| Operating Margin (Quarterly) | -124.3K% |
| Return on Net Operating Assets | -1.26K% |